John P. Quinn
Impact in
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 78
- Co-authors
- John W. McGrathMaría Virginia VillegasKaren LolansRobert A. WeinsteinVivien J. BubbAlasdair MacKenzieCarolyn E. FISKERSTRANDElizabeth A. Lovejoy
- Journals
- Antimicrobial Agents and Chemotherapy (26 papers)Neuropeptides (14 papers)Clinical Infectious Diseases (9 papers)International Journal of Molecular Sciences (9 papers)Journal of Molecular Neuroscience (9 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
John P. Quinn
403 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 193
- Molecular Medicine 5.3k
- Applied Microbiology and Biotechnology 1.6k
- Endocrinology 1.9k
- Clinical Biochemistry 1.8k
- Pollution 1.7k
Countries citing papers authored by John P. Quinn
This map shows the geographic impact of John P. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Quinn more than expected).
Fields of papers citing papers by John P. Quinn
This network shows the impact of papers produced by John P. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Quinn. The network helps show where John P. Quinn may publish in the future.
Co-authors
The 25 scholars most cited alongside John P. Quinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 10 | |
| 8 | 2019 | 27 | |
| 9 | 2018 | 12 | |
| 10 | 2016 | 14 | |
| 11 | 2010 | 122 | |
| 12 | 2008 | 387 | |
| 13 | Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles | 2008 | 2 |
| 14 | 2007 | 235 | |
| 15 | 2007 | 309 | |
| 16 | 2006 | 165 | |
| 17 | 2005 | 98 | |
| 18 | 2003 | 21 | |
| 19 | A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. | 2000 | 110 |
| 20 | Glufosinate tolerance and utilisation by soil and aquatic bacteria | 1993 | 4 |
About John P. Quinn
John P. Quinn is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Endocrinology, Cellular and Molecular Neuroscience and Pollution, having authored 408 papers that have together received 16.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (78 papers), Antibiotics Pharmacokinetics and Efficacy (33 papers), Neuropeptides and Animal Physiology (32 papers), Bacterial biofilms and quorum sensing (25 papers), RNA Research and Splicing (22 papers), Receptor Mechanisms and Signaling (20 papers), Pesticide and Herbicide Environmental Studies (19 papers) and Genetics and Neurodevelopmental Disorders (19 papers). The work is most often cited by research in Molecular Medicine (5.3k citations), Applied Microbiology and Biotechnology (1.6k citations), Endocrinology (1.9k citations), Clinical Biochemistry (1.8k citations) and Pollution (1.7k citations). John P. Quinn has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John W. McGrath, María Virginia Villegas, Karen Lolans, Robert A. Weinstein, Vivien J. Bubb, Alasdair MacKenzie, Carolyn E. FISKERSTRAND, Elizabeth A. Lovejoy, Adriana Correa and Larry H. Danziger. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Neuropeptides, Clinical Infectious Diseases, International Journal of Molecular Sciences and Journal of Molecular Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.